Table 3 Costs among HCV patients and controls
From: The burden of hepatitis C in Europe from the patients’ perspective: a survey in 5 countries
HCV Patients | Non-HCV | Matched controls | ||||||
|---|---|---|---|---|---|---|---|---|
(n = 286) | (n = 56,880) | (n = 286) | ||||||
Mean | SD | Mean | SD | p-value* | Mean | SD | p-value† | |
Indirect costs | ||||||||
Absenteeism | € 2,038.63 | € 6,048.12 | € 1,357.90 | € 5,326.81 | <.001 | € 1,253.43 | € 4,884.92 | .011 |
Presenteeism | € 5,493.91 | € 6,898.97 | € 3,368.88 | € 5,479.10 | <.001 | € 3,298.06 | € 5,454.64 | .001 |
Total indirect | € 7,532.54 | € 9,879.57 | € 4,729.20 | € 7,786.24 | <.001 | € 4,576.29 | € 7,365.19 | .002 |
Direct costs | ||||||||
Physician visits | € 486.61 | € 649.61 | € 288.54 | € 410.89 | <.001 | € 329.52 | € 536.32 | <.001 |
ER visits | € 71.68 | € 233.24 | € 40.72 | € 207.97 | .007 | € 42.94 | € 137.86 | .360 |
Hospitalizations | € 588.77 | € 1,867.19 | € 288.19 | € 2,754.17 | <.001 | € 279.62 | € 991.20 | .075 |
Total direct costs | € 1,147.06 | € 2,265.46 | € 617.45 | € 2,889.90 | <.001 | € 652.07 | € 1,373.94 | <.001 |
Total costs | € 4,587.54 | € 8,653.64 | € 3,291.01 | € 7,154.33 | <.001 | € 2,685.28 | € 5,530.30 | <.001 |